케모포트를 통해 항암화학요법을 받는 대장암 환자의 환자 활성화가 삶의 질에 미치는 영향

Abstract

Purpose: This study aimed to assess patient activation and quality of life levels in colorectal cancer patients receiving chemotherapy through a chemoport, as well as to investigate the factors influencing their quality of life. Methods: Research was conducted on 133 colorectal cancer patients receiving chemotherapy through a chemoport at the outpatient oncology clinic of a tertiary general hospital in Seoul. Patient activation and quality of life were evaluated using structured questionnaires. Data collection was conducted from March 14 to April 3, 2025, and the collected data were analyzed using IBM SPSS Statistics, version 27.0. Results: The results showed a mean patient activation of 57.00 ± 13.90 out of 100 and a mean quality of life of 82.99 ± 18.17 out of 136. In addition, there was a positive correlation between patient activation and quality of life (r=.18, p= .035). Multiple regression analysis revealed that previous chemoport insertion (β=-.32, p<.001) and patient activation (β=.17, p=.035) were significant predictors of quality of life in colorectal cancer patients undergoing chemotherapy. The model explained 12% of the variance (F=10.13, p<.001). Conclusion: Previous chemoport insertion history and patient activation were identified as significant factors influencing the quality of life of colorectal cancer patients receiving chemotherapy. Therefore, careful management is required for patients with a history of chemoport insertion, and practical, targeted interventions should be developed to enhance patient activation and improve quality of life throughout the treatment process.